Environmental Economist
tests financial-market implications.
Regions undergoing rapid renewable energy substitution (≥10% point increase in renewable share within 36 months) show measurable PM2.5 + NO₂ decline correlating with population-weighted life-expectancy increase within 24 months of transition acceleration.
Health-co-benefit valuations of climate policy gain rigorous methodology. Social-cost-of-carbon estimates revise upward by including quantified health gains.
This hypothesis is in the forming stage. Captain is accumulating the data stream necessary to detect the SUPPORTS or FALSIFIES condition with statistical significance. The metric — ΔPM2.5 + ΔNO₂ × population-weighting × mortality coefficient (per Global Burden of Disease) per region — needs to stabilise across the 5 endpoints, and the council has not yet seen enough data to assess proximity to either threshold.
Decision point: when enough data has accumulated to compute the metric with stable confidence intervals, the hypothesis advances to monitoring.
Metric: ΔPM2.5 + ΔNO₂ × population-weighting × mortality coefficient (per Global Burden of Disease) per region
Status: requires causal mediation panel (energy → PM2.5 → mortality)
/api/energy
loading
/api/aqi
loading
/api/openaq
loading
/api/air
loading
/api/worldbank
loading
Captain reads 5 Earth API endpoints together (/api/energy + /api/aqi + /api/openaq + /api/air + /api/worldbank). The hypothesis emerges only at their intersection — none of these streams alone reveals the pattern.
Region-level: energy mix change → PM2.5/NO₂ change → life-expectancy change. Multi-step regression. Test mediation effect of air quality.
tests financial-market implications.
designs the formal experiment.
Synthesises 2 angles into the formal hypothesis, sets thresholds, schedules revisits when data lands.
Five independent claude-sonnet-4-6 calls, one per persona — Skeptic, Fact-Checker, Researcher, Compliance-Guard, Falsification-Auditor. Each writes its hardest objection from its own seat, paired with the methodological resolution it would accept. Run on the static catalogue spec Jun 3, 2026; a live council for any topic is at /try.
The most potent alternative explanation is economic contraction or deindustrialization masquerading as a renewable transition effect. When heavy industry (steel, cement, chemicals) shuts down or contracts, the renewable share of total generation mechanically rises—because the fossil-fuel denominator shrinks—while PM2.5 and NO₂ fall due to reduced combustion activity entirely unrelated to new clean-energy capacity. Post-industrial regions in the EU Rust Belt and China's northeastern provinces exhibit exactly this co-occurrence: plant closures spike renewable share metrics by 10+ percentage points, simultaneously cut criteria pollutants, and alter population-weighted mortality through out-migration of working-age people rather than air-quality improvement. The World Bank GDP and industrial-output endpoints in /api/worldbank will not automatically disentangle these pathways in a naive mediation regression.
Instrument renewable-share change using staggered, exogenous policy-adoption dates—specifically the feed-in tariff and renewable portfolio standard enactment years from the IEA Policies and Measures database—via two-stage least squares (2SLS), which purges endogenous variation driven by economic downturns from the first-stage renewable-share regressor. Simultaneously, include quarterly industrial production indices from OECD STAN and regional GDP growth as covariates in both stages of the mediation model, and add a falsification test: if PM2.5/NO₂ declines in treated regions are matched by equivalent declines in industrial output (measured via Eurostat STS sector-level indices or China's NBS value-added data), attribute the air-quality signal to deindustrialization. The renewable-transition hypothesis survives only if the instrumented energy-mix → PM2.5/NO₂ → mortality path coefficient remains ≥0.3 deaths per 100k per 10-percentage-point renewable-share gain after controlling for industrial-output contraction; a coefficient collapse below 0.05 in this specification settles that deindustrialization, not clean-energy substitution, drives the observed pattern.
TROPOMI tropospheric NO₂ retrievals carry a systematic uncertainty of roughly 25% of column density plus pixel-level random noise of ~0.4–0.7 × 10¹⁵ molec/cm²; monthly regional PM2.5 estimated from MODIS/MAIAC aerosol optical depth translates that retrieval noise into ±2–4 μg/m³ (1-sigma) for surface concentrations. The OpenAQ endpoints aggregate heterogeneous networks mixing regulatory Federal Equivalent Method monitors (±10%) with low-cost electrochemical sensors (±20–40%), and the GBD concentration-response functions for PM2.5→mortality carry 95% credible intervals spanning roughly ±40% of their point estimates. Mapping the falsification threshold (0.05 deaths/100k per 10% renewable gain) and the support threshold (0.3 deaths/100k) back through GBD coefficients implies detecting mediating PM2.5 shifts of only ~0.05–0.3 μg/m³—well below the satellite retrieval noise floor—so neither threshold is independently resolvable from instrument noise alone.
Restrict OpenAQ/api/air pulls exclusively to government regulatory-grade reference monitors (OpenAQ `source_type = government`, flagged against EPA AQS or equivalent national networks), which compresses PM2.5 uncertainty to roughly ±1 μg/m³ for 24-month regional averages and makes a ≥2 μg/m³ change (~5σ) a credible detectability floor; re-set the SUPPORTS threshold to ≥2 μg/m³ PM2.5 decline accompanied by a ≥1.0 deaths/100k mediated effect using GBD lower-bound concentration-response. Apply TROPOMI NO₂ L2 product v2.3.1+ with quality-assurance flag ≥0.75 and aggregate over ≥24 monthly composites before testing the energy-mix→pollutant step, then propagate full GBD 95% credible-interval bounds through the mediation model via nonparametric bootstrap (≥5,000 draws), so that only effects surviving the combined instrument-plus-epidemiological uncertainty budget qualify as confirmatory.
The principal uncontrolled confounder is regional economic contraction or deindustrialization, which operates through a dual channel: a recession simultaneously (a) mechanically inflates the renewable-share metric by collapsing fossil-fuel consumption in the denominator, and (b) independently reduces PM2.5 and NO₂ by curtailing industrial throughput and road-freight activity, while (c) introducing mortality effects (positive via reduced occupational hazard, negative via income and healthcare-access shocks) that are wholly orthogonal to the energy transition. Because the design uses a 36-month transition window with no industrial-output control, any downturn-coincident transition episode will generate a spurious mediation path—energy mix → air quality → mortality—inflating the estimated co-benefit coefficient toward the support threshold.
The analysis should include region-year industrial-production index as a covariate (World Bank WDI series NV.IND.MANF.ZS, or national equivalents from UNIDO INDSTAT) and instrument the renewable-share change using ERA5 30-year climatological wind-capacity-factor and surface-solar-irradiance normals (ECMWF ERA5 variables 100m_u_component_of_wind and surface_solar_radiation_downwards, aggregated to region centroids) as supply-side shifters that are correlated with renewable buildout potential but uncorrelated with business-cycle fluctuations; a two-stage least-squares specification with this instrument isolates technology-driven substitution from demand-collapse-driven share increases, and the first-stage F-statistic can confirm instrument relevance while the exclusion restriction is defensible given that long-run wind and solar resources are geophysically determined.
Because the hypothesis explicitly predicts that social-cost-of-carbon (SCC) estimates will revise upward once health co-benefits are quantified, premature citation of this result could infect regulatory benefit-cost analyses prepared under OMB Circular A-4 and Executive Order 12866, distorting rulemakings conducted by the EPA under Clean Air Act Section 109 and greenhouse-gas proceedings governed by 40 CFR Part 98. Simultaneously, any corporate or fund-level disclosure that cites unvalidated health co-benefit valuations derived from this mediation chain risks violating SEC Rule 10b-5 (material misstatement in connection with a security) and the EU Corporate Sustainability Reporting Directive (CSRD) / IFRS S2 requirements for decision-useful, verifiable climate-related financial disclosures — particularly if the ≥0.3 deaths-per-100k effect size is presented as an established basis for asset valuation or policy lobbying before the SUPPORTS threshold is formally crossed.
The hypothesis must not be cited as supported in any regulatory filing, investor disclosure, or SCC working-group submission until the full mediation analysis — energy-mix → PM2.5/NO₂ → mortality — has achieved peer-reviewed publication with independent replication across at least two geographically distinct regional datasets drawn from sources other than the joined API endpoints used to derive the original result, and the combined mediation-path coefficient has been confirmed at p<0.05 with effect size ≥0.3 deaths per 100k per 10% renewable-share gain by an independent research team applying GBD mortality coefficients under documented, version-controlled methodology; until that threshold is formally certified, all downstream outputs must carry an explicit disclaimer stating that the mortality-reduction pathway remains a falsifiable hypothesis under active testing and is not suitable for inclusion in cost-benefit analyses, securities disclosures, or climate-policy valuations.
PM2.5 and NO₂ interannual variability driven by meteorology, wildfires, agricultural burning, and non-energy industrial activity is approximately 2–5 µg/m³ (1σ) in populated regions over 24-month windows, while the expected PM2.5 signal from a 10% renewable-share gain is roughly 0.5–1.5 µg/m³ in favorable cases. Translating through GBD concentration-response coefficients, this meteorological noise alone generates spurious apparent mortality-mediation effects of ±0.1–0.5 deaths per 100k—a range that straddles both the SUPPORTS threshold (≥0.3) and the FALSIFIES threshold (<0.05). Critically, rapid renewable transitions systematically co-occur with economic restructuring, concurrent emission regulations, and demographic change, meaning a well-calibrated null model (renewable gain assigned at random) may routinely produce estimated mediation effects above 0.05 even in the complete absence of a true energy-to-health pathway, making the FALSIFIES zone practically unreachable and the hypothesis functionally one-sided.
Run a Monte Carlo null experiment using 10,000 synthetic datasets in which the observed renewable-share gains are randomly permuted across region-year observations while retaining empirical PM2.5 time series drawn from an ensemble of reanalyses (ERA5, MERRA-2, CAMS) to preserve realistic meteorological variance; fit the identical mediation model to each permutation and record the 95th-percentile spurious mediation effect—if that percentile exceeds 0.05 deaths per 100k, the FALSIFIES threshold must be raised to match it. In parallel, add a synthetic-control arm that matches each transitioning region to a set of non-transitioning regions on pre-period PM2.5 trend, GDP growth rate, and industrial-emission intensity, then re-estimate the mediation effect on the residual after removing matched-control trajectories; this deconfounding step tightens the effective variance of the estimator and ensures the 0.05 deaths-per-100k boundary represents a signal level that noise alone genuinely cannot breach, giving the FALSIFIES condition real probability mass under the null.
Unlike the static stress tests above (synthesised against the frozen catalogue spec), this is what a 3-voice council found in the most recent biweekly review. Refreshed on the 1st and 15th of each month at 09:00 UTC. Each voice runs one bounded web search via Anthropic's web_search_20260209 tool, cites what it finds, and recommends a verdict.
The verdict diverges from the curated catalogue status (forming) — the synthesis below explains why.
The council collectively finds that while the energy-transition → air-quality → mortality pathway is mechanistically supported, the hypothesis as calibrated cannot be validated: model-projected benefits (2030–2050 horizons) dominate the literature rather than observed 24-month empirical data (Princeton/One Earth 2025), GBD PM2.5 mortality coefficients carry sufficient variance to span the entire FALSIFIES-to-SUPPORTS range depending on method choices (Burden of disease attributable to PM2.5 at low exposure levels, 2025), and PM2.5 spatial leakage across regional boundaries (41–53%) undermines the regional attribution logic central to the mediation path. The hypothesis requires revision to address the observational time-horizon, unit-of-analysis, and coefficient-precision constraints before it can be meaningfully tested or falsified.
The most recent literature (2025) corroborates the general energy-transition → air-quality → mortality pathway, but all supporting evidence is model-projected (2030–2050 horizons), not empirically observed in 24-month post-transition windows. Two structural problems contest the hypothesis as stated: (1) concentration–response functions vary substantially by location, season, and population subgroup, invalidating a universal GBD mortality coefficient; and (2) documented PM2.5 spatial leakage (41–53% of mortality crossing state lines) means a regional renewable-share gain cannot be cleanly attributed to local population-weighted life-expectancy improvement, likely making the mediation path non-significant or undetectable at the stated regional unit within 24 months.
This peer-reviewed study (PMC, June 2025) explicitly notes that concentration–response functions (CRF) linking PM2.5 to mortality 'vary by location, season, and time period' and are modulated by population demographics and socioeconomic status — directly undermining the hypothesis's assumption of a universal GBD mortality coefficient applicable within a 24-month window. All projected mortality reductions are modelled to 2050, not empirically observed over 24 months, leaving the short-term causal mediation pathway unvalidated.
This high-profile 2025 study projects 6,600 premature deaths avoided by 2030 under combined clean-energy scenarios, but does so via multi-scale modelling (energy system → air quality → health), not observed causal mediation within 24 months of transition acceleration. The projection-only design means the specific ≥0.3 deaths/100k/10%-renewable-gain threshold and the 24-month observational window remain empirically untested.
This study finds that 41–53% of PM2.5- and ozone-related premature mortality attributable to a state's combustion emissions occurs outside the emitting state, and ~70% of health damages from PM2.5 exposure occur in counties other than the emitting county. This severe spatial leakage structurally weakens any regional mediation analysis linking local renewable-share gains to local population-weighted life-expectancy increases within 24 months, because health benefits diffuse across distant regions rather than accruing locally.
The December 2025 methodological uncertainty analysis confirms that GBD PM2.5 mortality coefficients carry sufficient between-method variance to span the entire range from the FALSIFIES threshold (<0.05 deaths/100k) to well above the SUPPORTS threshold (≥0.3 deaths/100k) depending on exposure dataset and concentration-response curve selection; combined with iterative IER revisions across GBD vintages and sub-national source-attribution uncertainty, the instrument resolution is too coarse to reliably resolve a 0.3 vs. 0.05 deaths/100k distinction within a 24-month window, weakening but not wholly invalidating the hypothesis's calibration.
A 2025 multi-centre uncertainty analysis found that GBD-based PM2.5 burden-of-disease estimates are highly sensitive to the choice of concentration-response curve, population exposure dataset, and baseline mortality data, producing large between-method variance even for the same region. This directly challenges the hypothesis's fixed mortality coefficient approach: the uncertainty bands around the per-10%-renewable-share mortality coefficient may span the gap between the SUPPORTS threshold (≥0.3 deaths/100k) and the FALSIFIES threshold (<0.05 deaths/100k), meaning a single point estimate from GBD may not reliably discriminate between them.
This GBD-linked multi-scale attribution study demonstrated that energy-sector PM2.5 contributions vary substantially by region and spatial resolution, and that attributable mortality estimates depend heavily on source-sector apportionment models. The hypothesis assumes a clean energy-mix → PM2.5 → mortality pathway with a single pooled coefficient, but sector-specific attribution uncertainty at sub-national scales weakens the precision of that mediating path, particularly for short (24-month) observation windows.
The integrated exposure-response (IER) functions underpinning the hypothesis's GBD mortality coefficients were calibrated on 2010 concentration data and embed a nonlinear concentration-response relationship; subsequent GBD rounds (2017, 2019, 2021) have iteratively revised these IER curves, meaning the exact per-unit mortality coefficient used in the SUPPORTS threshold may be drawn from a superseded calibration vintage and should be updated to GBD 2021 values.
While the scientific mechanism linking renewable transitions to PM2.5/NO₂ mortality reduction retains empirical support, the regulatory scaffolding needed to make the hypothesis 'policy-relevant' has materially eroded: the SEC rule is abandoned, ISSB/IFRS S2 does not mandate health co-benefit accounting, and no major standard-setter has operationalized GBD-linked mortality coefficients in mandatory disclosure. The hypothesis's downstream prediction—that social-cost-of-carbon estimates revise upward via quantified health gains—currently lacks a regulatory pathway to compel that revision at scale.
The SEC voted in March 2025 to abandon defense of its 2024 climate disclosure rule, removing a federal mandate for health-co-benefit quantification in corporate filings. This weakens policy pressure on U.S. issuers to disclose the mortality-reduction co-benefits the hypothesis predicts, though California's SB 253 (CARB-approved February 2026) partially fills that gap for large firms.
On June 23, 2025, the ISSB released guidance integrating transition-plan disclosures into IFRS S2, the climate-reporting standard. Because IFRS S2 focuses on financial risks rather than health co-benefits (PM2.5/NO₂ mortality pathways), the hypothesis's prediction that 'health-co-benefit valuations gain rigorous methodology' is not yet embedded in the dominant global disclosure framework.
A systematic review of 58 quantitative studies across 125 net-zero scenarios confirms air-quality pathways (PM2.5/NO₂ → mortality) are real, but finds the magnitude is highly context-specific and poorly documented—supporting the hypothesis's scientific mechanism while signaling that the ≥0.3 deaths/100k threshold may not be universally achievable within 24 months without accompanying direct air-pollution controls.
Agent draft incorporating the 9 cited findings from the live council above. Not auto-merged — surfaces here for human review. To accept, open a PR editing site/src/_data/hypotheses.json with the revised fields below. To reject, ignore and the proposal will refresh on the next council run.
Three structural problems identified in recent literature require targeted revision: (1) Princeton/One Earth 2025 and the PMC June 2025 subpopulation study show that all quantified mortality benefits operate on 2030–2050 model horizons, not observed 24-month windows, making the current 24-month observational claim empirically unsupported; (2) the 2022 nationwide PM2.5 spatial-leakage study (41–53% of mortality crossing state lines) and the GBD-linked Nature Communications 2021 multi-scale attribution study demonstrate that a single-region unit of analysis cannot cleanly capture the mortality mediation path, requiring a multi-region or pooled spatial unit; (3) the 2025 NIPH/WHO/GBD uncertainty analysis confirms that GBD PM2.5 mortality coefficients carry between-method variance sufficient to span the entire FALSIFIES-to-SUPPORTS range, meaning the current fixed-coefficient thresholds are not reliably discriminable — the thresholds must be recalibrated to a wider, instrument-resolvable gap and the metric must specify GBD 2021 IER vintage and CRF sensitivity bounds.
Extended observational window from 24 months to 36–60 months; shifted unit of analysis from single region to contiguous multi-region unit (≥3 states/NUTS-2) to account for 41–53% cross-boundary PM2.5 mortality leakage; recalibrated SUPPORTS threshold from ≥0.3 to lower-bound-of-CI ≥0.15 deaths/100k across ≥2 of 3 CRF specs to reflect GBD coefficient uncertainty; added mandatory GBD 2021 IER vintage and 3-CRF sensitivity reporting requirement to metric; updated FALSIFIES to require null result across all 3 CRF specifications to remain enterable under instrument uncertainty; revised PREDICTS to drop regulatory-pathway language (SEC/ISSB findings) in favour of methodology-convergence framing.
Regions undergoing rapid renewable energy substitution (≥10% point increase in renewable share within 36 months) show measurable PM2.5 + NO₂ decline correlating with population-weighted life-expectancy increase within 24 months of transition acceleration.
Multi-region spatial units undergoing rapid renewable energy substitution (≥10 percentage-point increase in renewable share within 36 months) show statistically detectable PM2.5 + NO₂ decline that, when propagated through GBD 2021 concentration-response functions and corrected for cross-boundary pollution transport, is associated with a projected population-weighted mortality reduction within a 5-year attribution window.
ΔPM2.5 + ΔNO₂ × population-weighting × mortality coefficient (per Global Burden of Disease) per region
ΔPM2.5 + ΔNO₂ × population-weighting × GBD 2021 IER mortality coefficient (with sensitivity bounds reported across at least 3 concentration-response curve specifications), aggregated over a contiguous multi-region unit (≥3 contiguous states or NUTS-2 equivalents) to partially absorb spatial leakage; mortality effect expressed as deaths per 100k per 10% renewable-share gain with 95% uncertainty interval reported
Mediation analysis: energy-mix → PM2.5/NO₂ → mortality path significant (p<0.05) with combined effect ≥ 0.3 deaths per 100k per 10% renewable-share gain
Mediation analysis: energy-mix → PM2.5/NO₂ → projected mortality path significant (p<0.05) with lower bound of 95% uncertainty interval ≥ 0.15 deaths per 100k per 10% renewable-share gain across ≥2 of 3 CRF specifications, sustained over a 36–60 month observation window
Mediation path effect < 0.05 deaths per 100k per 10% renewable-share gain, OR PM2.5/NO₂ shows no statistically detectable change post-transition
Mediation path central estimate < 0.05 deaths per 100k per 10% renewable-share gain across all 3 CRF specifications, OR PM2.5/NO₂ shows no statistically detectable change (at α=0.05) at the multi-region spatial unit post-transition over the 36–60 month window — a condition enterable under the null given current TROPOMI/OpenAQ instrument resolution and GBD 2021 coefficient precision
Health-co-benefit valuations of climate policy gain rigorous methodology. Social-cost-of-carbon estimates revise upward by including quantified health gains.
Health-co-benefit quantification methodologies for climate policy converge on multi-region spatial aggregation and multi-CRF sensitivity reporting as minimum standards. Social-cost-of-carbon estimates in integrated assessment models incorporate GBD 2021–calibrated mortality co-benefits as a documented uncertainty range rather than a single point estimate, enabling upward revision in central estimates once empirical multi-year regional datasets accumulate.
This peer-reviewed study (PMC, June 2025) explicitly notes that concentration–response functions (CRF) linking PM2.5 to mortality 'vary by location, season, and time period' and are modulated by population demographics and socioeconomic status — directly undermining the hypothesis's assumption of a universal GBD mortality coefficient applicable within a 24-month window. All projected mortality reductions are modelled to 2050, not empirically observed over 24 months, leaving the short-term causal mediation pathway unvalidated.
This high-profile 2025 study projects 6,600 premature deaths avoided by 2030 under combined clean-energy scenarios, but does so via multi-scale modelling (energy system → air quality → health), not observed causal mediation within 24 months of transition acceleration. The projection-only design means the specific ≥0.3 deaths/100k/10%-renewable-gain threshold and the 24-month observational window remain empirically untested.
This study finds that 41–53% of PM2.5- and ozone-related premature mortality attributable to a state's combustion emissions occurs outside the emitting state, and ~70% of health damages from PM2.5 exposure occur in counties other than the emitting county. This severe spatial leakage structurally weakens any regional mediation analysis linking local renewable-share gains to local population-weighted life-expectancy increases within 24 months, because health benefits diffuse across distant regions rather than accruing locally.
A 2025 multi-centre uncertainty analysis found that GBD-based PM2.5 burden-of-disease estimates are highly sensitive to the choice of concentration-response curve, population exposure dataset, and baseline mortality data, producing large between-method variance even for the same region. This directly challenges the hypothesis's fixed mortality coefficient approach: the uncertainty bands around the per-10%-renewable-share mortality coefficient may span the gap between the SUPPORTS threshold (≥0.3 deaths/100k) and the FALSIFIES threshold (<0.05 deaths/100k), meaning a single point estimate from GBD may not reliably discriminate between them.
This GBD-linked multi-scale attribution study demonstrated that energy-sector PM2.5 contributions vary substantially by region and spatial resolution, and that attributable mortality estimates depend heavily on source-sector apportionment models. The hypothesis assumes a clean energy-mix → PM2.5 → mortality pathway with a single pooled coefficient, but sector-specific attribution uncertainty at sub-national scales weakens the precision of that mediating path, particularly for short (24-month) observation windows.
The integrated exposure-response (IER) functions underpinning the hypothesis's GBD mortality coefficients were calibrated on 2010 concentration data and embed a nonlinear concentration-response relationship; subsequent GBD rounds (2017, 2019, 2021) have iteratively revised these IER curves, meaning the exact per-unit mortality coefficient used in the SUPPORTS threshold may be drawn from a superseded calibration vintage and should be updated to GBD 2021 values.
The SEC voted in March 2025 to abandon defense of its 2024 climate disclosure rule, removing a federal mandate for health-co-benefit quantification in corporate filings. This weakens policy pressure on U.S. issuers to disclose the mortality-reduction co-benefits the hypothesis predicts, though California's SB 253 (CARB-approved February 2026) partially fills that gap for large firms.
On June 23, 2025, the ISSB released guidance integrating transition-plan disclosures into IFRS S2, the climate-reporting standard. Because IFRS S2 focuses on financial risks rather than health co-benefits (PM2.5/NO₂ mortality pathways), the hypothesis's prediction that 'health-co-benefit valuations gain rigorous methodology' is not yet embedded in the dominant global disclosure framework.
A systematic review of 58 quantitative studies across 125 net-zero scenarios confirms air-quality pathways (PM2.5/NO₂ → mortality) are real, but finds the magnitude is highly context-specific and poorly documented—supporting the hypothesis's scientific mechanism while signaling that the ≥0.3 deaths/100k threshold may not be universally achievable within 24 months without accompanying direct air-pollution controls.
This is an original cross-correlation hypothesis. The pattern emerges only when 5 Earth API endpoints are read together; no single dataset or existing publication isolates the claim as stated here. Captain proposes it as a testable scientific question.
Captain Landseed. (May 30, 2026). Clean-energy transitions deliver measurable mortality reduction within 24 months [Working hypothesis, forming, catalogue v6.3]. Landseed PBC. Retrieved Jun 6, 2026 from https://captain-landseed.pages.dev/h/air-pollution-mortality-action-gap/
@misc{captain_landseed_air_pollution_mortality_action_gap,
author = {Captain Landseed},
title = {Clean-energy transitions deliver measurable mortality reduction within 24 months},
year = {May 30 2026},
howpublished = {Working hypothesis, status: forming, catalogue v6.3},
publisher = {Landseed PBC},
url = {https://captain-landseed.pages.dev/h/air-pollution-mortality-action-gap/},
note = {Module: anthroposphere; Originality: NOVEL; Accessed: Jun 6, 2026}
}
TY - GEN AU - Captain Landseed TI - Clean-energy transitions deliver measurable mortality reduction within 24 months PY - May 30 2026 PB - Landseed PBC UR - https://captain-landseed.pages.dev/h/air-pollution-mortality-action-gap/ N1 - Working hypothesis (status: forming); catalogue v6.3; module: anthroposphere ER -
JSON snapshot with all hypotheses, archived council deliberations, current live-state, and the build-over-build activity log. SHA-256 manifest included. CC-BY-4.0.
Five personas deliberate in real time. Typically ~$0.08, 40-60 seconds. Three free runs, then bring-your-own Anthropic / OpenAI / Gemini.